Bevacizumab Intravenous and Kisqali Femara Co-Pack 200 mg-2.5 mg Dose

• Generic Name: bevacizumab
• Dosage Forms: n.a.
• Other Brand Names: Avastin, Mvasi

Bevacizumab injection is given with other medicines to treat patients with metastatic (cancer that has spread) carcinoma of the colon or rectum. Bevacizumab is also used to treat a certain type of metastatic lung cancer called nonsquamous, non-small cell lung cancer, and a certain type of brain tumor called glioblastoma that keeps coming back (recurrent).

Bevacizumab injection is also used in combination with other medicines (eg, interferon alfa) to treat patients with metastatic kidney cancer. It is also used in combination with other medicines (eg, paclitaxel and cisplatin, or paclitaxel and topotecan) to treat patients with cervical cancer that is continuing, keeps coming back, or has spread to other parts of the body. Bevacizumab is also used in combination with other medicines (eg, paclitaxel, pegylated liposomal doxorubicin, topotecan, carboplatin and paclitaxel, or carboplatin and gemcitabine followed by Avastin® alone) to treat patients with platinum-resistant, recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer with or without having previous surgery.

Bevacizumab is a substance that helps the body fight cancer. It prevents the growth of certain types of blood vessels to cancer cells. This helps to decrease the growth of cancer cells by starving the cells of nutrients that are needed to grow.

Bevacizumab is to be given only by or under the immediate supervision of your doctor.

• Generic Name: letrozole / ribociclib
• Dosage Forms: kit
• Other Brand Names: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose

Letrozole lowers estrogen levels, which may slow the growth of certain types of breast tumors that need estrogen to grow in the body.

Ribociclib interferes with the growth and spread of cancer cells in the body.

Kisqali Femara Co-Pack 200 mg-2.5 mg Dose are used together in combination to treat HR-positive, HER2-negative breast cancer in women.

Kisqali Femara Co-Pack 200 mg-2.5 mg Dose is used when the cancer has spread to other parts of the body (metastatic).

Kisqali Femara Co-Pack 200 mg-2.5 mg Dose are two different medicines that are packaged together. Letrozole tablets are yellow and ribociclib tablets are violet.

Kisqali Femara Co-Pack 200 mg-2.5 mg Dose may also be used for purposes not listed in this medication guide.